Third-party certification programs, when referenced in official policy, represent one approach to mitigating inadvertent exposure, although they do not constitute a guarantee of compliance
Identity, purity, sterility, strength, shipping, storage, and licensing must still be evaluated for the specific source
The FDA has not issued an outright enforcement ban specifically targeting AOD-9604 compounding as of mid-2025, but the agency has broad authority to act against pharmacies using bulk substances not on the approved list
Taking five extra seconds to inject slowly makes a noticeable difference in how the site feels afterward
The side effects might be either due to high dose of vitamin B12 or allergic reaction to its composition
& Feron, O